AOA Dx, Inc
AOA will revolutionize early-stage diagnosis of ovarian cancer by developing AKRIVIS GD, an accurate liquid biopsy that detects gangliosides which are specific to cancer.
AOA will revolutionize early-stage diagnosis of ovarian cancer by developing AKRIVIS GD, an accurate liquid biopsy that detects gangliosides which are specific to cancer.